BUDGET IMPACT ANALYSIS OF THE INCLUSION OF TOFACITINIB AS AN ALTERNATIVE FOR RHEUMATOID ARTHRITIS TREATMENT AFTER CONVENTIONAL DMARDS FAILURE IN CHILE
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1123
https://www.valueinhealthjournal.com/article/S1098-3015(16)01191-8/fulltext
Title :
BUDGET IMPACT ANALYSIS OF THE INCLUSION OF TOFACITINIB AS AN ALTERNATIVE FOR RHEUMATOID ARTHRITIS TREATMENT AFTER CONVENTIONAL DMARDS FAILURE IN CHILE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01191-8&doi=10.1016/j.jval.2016.03.1123
First page :
A228
Section Title :
Muscular-Skeletal Disorders - Cost Studies
Open access? :
No
Section Order :
791